FYERS
Home
/
Stocks
/
Profit Loss
/
Rubicon Research Profit & Loss

Rubicon Research Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
₹534 Cr₹514 Cr₹476 Cr₹412 Cr₹352 Cr₹358 Cr₹313 Cr₹296 Cr
₹6 Cr₹3 Cr₹4 Cr₹70 L₹63 L₹10 L₹49 L₹3 Cr
₹540 Cr₹517 Cr₹479 Cr₹413 Cr₹353 Cr₹358 Cr₹314 Cr₹299 Cr
₹420 Cr₹407 Cr₹379 Cr₹330 Cr₹283 Cr₹295 Cr₹253 Cr₹242 Cr
₹135 Cr₹121 Cr₹112 Cr₹95 Cr₹80 Cr₹73 Cr₹70 Cr₹64 Cr
₹9 Cr₹10 Cr₹10 Cr₹11 Cr₹11 Cr₹12 Cr₹8 Cr₹7 Cr
₹110 Cr₹99 Cr₹91 Cr₹72 Cr₹60 Cr₹51 Cr₹53 Cr₹49 Cr
₹85 Cr₹77 Cr₹73 Cr₹54 Cr₹43 Cr₹36 Cr₹38 Cr₹34 Cr

Share Price Live Stats

Open (₹)1,788.80
Volume (₹)1.14 L
High (₹)1,792.00
Upper Circuit2,130.80
Low (₹)1,752.20
Lower Circuit1,420.60
Prev Close1,775.70
52W High (₹)1,899.00
Price1,768.30
52W Low (₹)570.75

Share Market Cap & Key Ratios Overview

M.Cap (₹)29367.80 Cr
Div. Yield (%)0.08
PE Ratio101.90
Debt to Equity0.21
Price to Book10.14
Book Value76.17
EPS (TTM)17.41
Face Value1.00
ROE (%)27.84

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
RUBICONNSE
LTP
1W Low
1W High
Market cap (₹)
1899-21 (-1.09%)
1895
1984.80
4,56,833Cr
9100-139 (-1.50%)
9087
9467
2,45,426Cr
4857-193 (-3.82%)
4823
5066
1,87,320Cr
1120-71 (-5.96%)
1120
1187
1,13,217Cr
1385-38.5 (-2.70%)
1375.50
1426.10
1,12,212Cr
1840-98.5 (-5.08%)
1811.70
1949
1,01,155Cr
2110-61.5 (-2.83%)
2100.60
2192
97,626Cr
2327.9-55 (-2.31%)
2317
2419.20
96,859Cr
1151-27 (-2.29%)
1151
1179.90
96,406Cr
1653.1+7.8 (0.47%)
1622.60
1717
93,614Cr
1768.3-36.1 (-2.00%)
1752.20
1875
29,368Cr

Key Highlights of Rubicon Research Ltd’s P&L

In 2026-03-31, Rubicon Research Ltd reported total revenue of ₹1762.66Cr, compared with ₹1296.22Cr in 2025-03-31, reflecting Rubicon Research Ltd turnover.

Depreciation was ₹45.26Cr and finance costs were ₹42.17Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹320.53Cr in 2026-03-31 as compared to ₹194.52Cr in 2025-03-31.

Net Profit (PAT) was ₹246.74Cr in 2026-03-31 compared with ₹134.36Cr in 2025-03-31.

Earnings per share (EPS) were ₹14.95 in 2026-03-31, compared with ₹8.72 in 2025-03-31.